5th ENOVA Adjuvant Workshop

Make space in your calendar for the 5th ENOVA workshop on adjuvants in Belgrade, Serbia. Time March 28-33 - 2022. More info will follow soon

Belgrade

Agenda Monday March 28th 2022

12:00 – 13:00 Registration (light snacks will be provided)
Introduction & Keynote
13.00 – 13.30 Introduction to ENOVA & the 5th Adjuvant Workshop, Dennis Christensen (SSI, DK)
13.30 – 13.45 Summary of ENOVA survey, Anita Milicic (University of Oxford, UK) - online
13.45 – 14.15 European infrastructures for vaccine research, Ole Olsen (European Vaccine Initiative, DE)
14.15 – 14.45 Coffee break
14.45 – 16.45 Lightning talks I (4’/presentation)
Session 1: Vaccine adjuvants in infectious diseases and cancer
16.50 – 17.15 Novel adjuvant combinations for a pandemic influenza vaccine, Allegra Peletta (University of Geneva, CH)
17.15 – 17.40 Listeria nanovaccines for cancer treatment (tbc), Carmen Alvarez Dominguez (Instituto de Investigación Marqués de Valdecilla, ES) – online
17.40 – 18.05 NETs-stimulating nanoparticles as novel adjuvants, Rostyslav Bilyy (National Medical University, UA) – pre-recorded video
Evening on your own


Agenda Tuesday March 29th 2022

8:30 – 10:30 MC meeting (only for members of the Management Committee)
10.00 – 11.10 Coffee break


Session 2: Mechanism of vaccine adjuvants
11.10 – 11.30 A Mucosal Nipah Virus Vaccine for Pigs based on a Paramyxovirus vector, Louise Cosby (Agri-Food and Biosciences Institute, UK) - online
11.30 – 11.50 Investigating the Mechanism of novel Saponin-Based Adjuvants, Sören Reinke (Oxford University, UK) - online
11.50 – 12.10 Employing adjuvants in pan-viral prophylactic strategies, Julie Zimmermann (SSI, DK)
12.10 – 12.30 Exploring the adjuvant selection criteria for therapeutic vaccination against chronic hepatitis B, Jinpeng Su (Technical University München, DE) - online


12.30 – 13.30 Lunch


13.30 – 15.00 Lightning talks II (4’/presentation)
15.00 – 15.30 Coffee break


Session 3: Adjuvant technologies
15.30 – 15.50 Microneedle technologies and liposomal delivery systems for (cancer) vaccination, Koen van der Maaden (University of Leiden, NL)
15.50 – 16.10 Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b, Signe Tandrup Schmidt (SSI, DK)
16.10 – 16.30 Design and synthesis of a new STnThr analogue based on a TnThr antigen mimetic, Valerio Zullo (University of Florence, IT) - online
16.30 – 17.00 Development status of CAF adjuvants, Dennis Christensen (SSI, DK)
17.00 – 17.30 VFI vaccine adjuvants for global health, Celine Lemoine (Vaccine Formulation Institute, CH)
19.00 Dinner at restaurant


Agenda Wednesday March 30th 2022

9.00 – 9.30 Summary of MC meeting discussions
Session 4: Novel adjuvant components
9.30 – 9.50 Novel synthetic glycolipid adjuvant candidates targeting TLR4, Alla Zamyatina (University of Natural Resources and Life Sciences, AT)
9.50 – 10.10 Development of saponin-based synthetic adjuvants and molecular vaccines, Alberto Fernández-Tejada (CIC bioGUNE, ES) - online
10.10 – 11.00 Coffee break
Closing of the meeting
11.00 – 12.00 The future of ENOVA, Dennis Christensen/Ed Lavelle
12.00 – 12.30 Closing remarks, Maria Lawrenz (Vaccine Formulation Institute, CH

Published Dec. 2, 2021 11:26 PM - Last modified Mar. 22, 2022 1:32 PM